-
Russia’s global vaccine ambitions stumble during supply shortage
firstwordpharma
August 02, 2021
Deliveries of Russia's Sputnik V COVID-19 vaccine have been hampered, forcing countries to seek alternatives, Bloomberg reported.
-
QPS Supports COVID-19 Vaccine Development In Taiwan, China
prnewswire
August 02, 2021
QPS, a global contract research organization (CRO) focused on bioanalytics and clinical trials, is honored to have collaborated with Medigen Vaccine Biologics Corporation to complete toxicology studies necessary for the development of a COVID-19 vaccine.
-
CDC Now Says Vaccinated Should Be Tested After COVID-19 Exposure, Even Without Symptoms
drugs
July 30, 2021
People fully vaccinated against COVID-19 should be tested for the virus if they come into contact with infected people, whether or not they have symptoms, say updated testing guidelines from the U.S. Centers for Disease Control and Prevention.
-
Vaccinated Americans Can Soon Visit the U.K. Without Quarantining
drugs
July 29, 2021
Starting Aug. 2, the United Kingdom will allow fully vaccinated travelers from the United States into the country without having to quarantine upon arrival, officials there announced Wednesday.
-
Pfizer Says Third Shot of Vaccine Boosts COVID-19 Protection
drugs
July 29, 2021
New data show that protection from both doses of the Pfizer COVID-19 vaccine decreases slightly over time but that a third dose significantly boosts levels of antibodies against several variants of the virus, including the highly contagious delta variant.
-
Data show steady drop-off in protection with Pfizer's COVID-19 vaccine
firstwordpharma
July 29, 2021
The effectiveness of Pfizer and partner BioNTech's coronavirus vaccine BNT162b2 steadily declines over time, slipping to roughly 84% for vaccinated people about four to six months after they got their second dose, according to data released Wednesday.
-
Pfizer, Moderna to Expand Vaccine Studies in Young Children
drugs
July 28, 2021
Pfizer and Moderna are expanding trials of their COVID-19 vaccines in children ages 5 to 11 years to more closely measure the risk for heart inflammation and other rare side effects that occurred in teens and young adults who received the vaccines.
-
Empty Stadiums, COVID Fears: How Will It Affect Olympic Athletes?
drugs
July 23, 2021
To do their best, Olympic athletes need to be both physically and mentally fit, but the COVID-19 pandemic and its restrictions at the Tokyo Olympics has made that a real challenge, experts say.
-
Biden Says Full Approval for COVID-19 Vaccines Coming Soon
drugs
July 23, 2021
As he urged Americans who are still hesitant to get vaccinated, President Joe Biden told an Ohio town hall on Wednesday night that he expected the U.S. Food and Drug Administration would soon give final approval to COVID-19 vaccines.
-
Vaccine biotech Icosavax sets terms for $150 million IPO
firstwordpharma
July 23, 2021
Icosavax plans to raise $150 million in its initial public offering by offering 10 million shares at a price range of $14 to $16, as reported by NASDAQ.